Boryung Corporation

KOSE:A003850 Stock Report

Market Cap: ₩773.0b

Boryung Dividend

Dividend criteria checks 2/6

Boryung ist ein dividendenzahlendes Unternehmen mit einer aktuellen Rendite von 0.84%, die durch die Erträge gut gedeckt ist.

Key information

0.9%

Dividend yield

16%

Payout ratio

Industry average yield1.1%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share₩605.40
Dividend yield forecast in 3Y0.9%

Recent dividend updates

Recent updates

Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

Apr 06
Why We're Not Concerned About Boryung Corporation's (KRX:003850) Share Price

A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Apr 28
A Look At The Fair Value Of Boryung Pharmaceutical Co., Ltd. (KRX:003850)

Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Mar 17
Boryung Pharmaceutical (KRX:003850) Has A Pretty Healthy Balance Sheet

Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Feb 27
Here's How We Evaluate Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Dividend

Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 09
Is Boryung Pharmaceutical Co., Ltd.'s (KRX:003850) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Jan 25
Do Institutions Own Boryung Pharmaceutical Co., Ltd. (KRX:003850) Shares?

Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

Jan 10
Should You Use Boryung Pharmaceutical's (KRX:003850) Statutory Earnings To Analyse It?

If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Dec 23
If You Had Bought Boryung Pharmaceutical (KRX:003850) Shares Three Years Ago You'd Have Earned 122% Returns

Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Dec 08
Is Boryung Pharmaceutical (KRX:003850) A Risky Investment?

Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Nov 23
Would Boryung Pharmaceutical Co., Ltd. (KRX:003850) Be Valuable To Income Investors?

Stability and Growth of Payments

Fetching dividends data

Stabile Dividende: Während die Dividendenzahlungen stabil waren, zahlt A003850 seit weniger als 10 Jahren eine Dividende.

Wachsende Dividende: A003850Die Dividendenzahlungen des Unternehmens sind gestiegen, aber das Unternehmen zahlt erst seit 4 Jahren eine Dividende.


Dividend Yield vs Market

Boryung Dividend Yield vs Market
How does A003850 dividend yield compare to the market?
SegmentDividend Yield
Company (A003850)0.9%
Market Bottom 25% (KR)1.0%
Market Top 25% (KR)3.6%
Industry Average (Pharmaceuticals)1.1%
Analyst forecast in 3 Years (A003850)0.9%

Bemerkenswerte Dividende: A003850Die Dividende des Unternehmens (0.9%) ist im Vergleich zu den unteren 25 % der Dividendenzahler auf dem Markt KR (1.01%) nicht bemerkenswert.

Hohe Dividende: A003850Die Dividende des Unternehmens (0.9%) ist im Vergleich zu den besten 25% der Dividendenzahler auf dem Markt KR (3.52%) niedrig.


Earnings Payout to Shareholders

Abdeckung der Erträge: Mit seiner niedrigen Ausschüttungsquote (23.3%) sind die Dividendenzahlungen von A003850 gut durch die Erträge gedeckt.


Cash Payout to Shareholders

Cashflow-Deckung: Mit einer relativ niedrigen Ausschüttungsquote (34.4%) sind die Dividendenzahlungen von A003850 durch den Cashflow gut gedeckt.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.